KR101336505B1 - 림프계의 영상화 방법 - Google Patents

림프계의 영상화 방법 Download PDF

Info

Publication number
KR101336505B1
KR101336505B1 KR1020097005378A KR20097005378A KR101336505B1 KR 101336505 B1 KR101336505 B1 KR 101336505B1 KR 1020097005378 A KR1020097005378 A KR 1020097005378A KR 20097005378 A KR20097005378 A KR 20097005378A KR 101336505 B1 KR101336505 B1 KR 101336505B1
Authority
KR
South Korea
Prior art keywords
delete delete
site
mammal
lymphatic system
contrast agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020097005378A
Other languages
English (en)
Korean (ko)
Other versions
KR20090045343A (ko
Inventor
빈센트 자크
피터 디. 캐러밴
베른트 미셀비츠
한스-요하힘 바인만
Original Assignee
에픽스 파마슈티칼스, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 에픽스 파마슈티칼스, 인코포레이티드 filed Critical 에픽스 파마슈티칼스, 인코포레이티드
Publication of KR20090045343A publication Critical patent/KR20090045343A/ko
Application granted granted Critical
Publication of KR101336505B1 publication Critical patent/KR101336505B1/ko
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
    • A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/418—Evaluating particular organs or parts of the immune or lymphatic systems lymph vessels, ducts or nodes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Endocrinology (AREA)
  • General Physics & Mathematics (AREA)
  • Signal Processing (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
KR1020097005378A 2006-08-17 2007-08-16 림프계의 영상화 방법 Expired - Fee Related KR101336505B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US83848806P 2006-08-17 2006-08-17
US60/838,488 2006-08-17
PCT/US2007/076109 WO2008022263A2 (en) 2006-08-17 2007-08-16 Methods for lymph system imaging

Publications (2)

Publication Number Publication Date
KR20090045343A KR20090045343A (ko) 2009-05-07
KR101336505B1 true KR101336505B1 (ko) 2013-12-05

Family

ID=39083140

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020097005378A Expired - Fee Related KR101336505B1 (ko) 2006-08-17 2007-08-16 림프계의 영상화 방법

Country Status (7)

Country Link
US (1) US20080044358A1 (enExample)
EP (1) EP2053968A4 (enExample)
JP (1) JP5563299B2 (enExample)
KR (1) KR101336505B1 (enExample)
CN (1) CN101528124A (enExample)
CA (1) CA2660717A1 (enExample)
WO (1) WO2008022263A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090024022A1 (en) * 2006-10-25 2009-01-22 Siemens Corporate Research, Inc. System and method for lymph node imaging using co-registration of ct and mr imagery
US10076264B2 (en) 2013-03-31 2018-09-18 Case Western Reserve University System and method for quantitative magnetic resonance (MR) analysis using T1 mapping
US9747789B2 (en) * 2013-03-31 2017-08-29 Case Western Reserve University Magnetic resonance imaging with switched-mode current-source amplifier having gallium nitride field effect transistors for parallel transmission in MRI
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
CN110035996B (zh) 2016-11-28 2022-08-09 拜耳医药股份公司 用于磁共振成像的新型高弛豫性钆螯合物
JOP20210114A1 (ar) 2018-11-23 2023-01-30 Bayer Ag تركيبة وسط تباين وعملية لتحضيرها
WO2020163286A1 (en) * 2019-02-04 2020-08-13 Massachusetts Institute Of Technology Systems and methods for lymph nodes and vessels imaging
WO2023177683A1 (en) * 2022-03-14 2023-09-21 The Board Of Trustees Of The Leland Stanford Junior University Devices, systems, and methods for treating volume overload

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118103A1 (en) 1997-10-02 2005-06-02 Epix Medical, Inc., A Delaware Corporation Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
US20060093554A1 (en) 1999-09-29 2006-05-04 Johannes Platzek Galenical formulations
US20060099148A1 (en) 2004-01-15 2006-05-11 Mount Sinai School Of Medicine Methods and compositions for imaging

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0289304A (ja) * 1988-09-27 1990-03-29 Kitamura Kiden Kk 巻鉄心用帯材の切抜方法
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5843399A (en) * 1990-04-06 1998-12-01 Schering Aktiengesellschaft DTPA monoamides for MRI
DE4011684A1 (de) * 1990-04-06 1991-10-10 Schering Ag Dtpa-monoamide, diese verbindungen enthaltende pharmazeutische mittel, ihre verwendung und verfahren zu deren herstellung
EP0654973A4 (en) * 1992-07-21 1995-08-09 Gen Hospital Corp ARRANGEMENT FOR DELIVERING MEDICINES TO THE LYMPHIC TISSUE.
GB9216082D0 (en) * 1992-07-28 1992-09-09 Univ Nottingham Lymphatic delivery composition
TW319763B (enExample) * 1995-02-01 1997-11-11 Epix Medical Inc
DE19525924A1 (de) * 1995-07-04 1997-01-09 Schering Ag Kaskaden-Polymer-Komplexe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
JPH10120597A (ja) * 1996-10-22 1998-05-12 Eiken Chem Co Ltd リンパ節高集積性コロイド粒子
US6444192B1 (en) * 1999-02-05 2002-09-03 The Regents Of The University Of California Diagnostic imaging of lymph structures
AU5270500A (en) * 1999-05-14 2000-12-05 Regents Of The University Of California, The Macromolecular carrier for drug and diagnostic agent delivery
US6652835B1 (en) * 1999-07-29 2003-11-25 Epix Medical, Inc. Targeting multimeric imaging agents through multilocus binding
US6818203B2 (en) * 2000-08-11 2004-11-16 Schering Aktiengesellschaft Use of perfluoroalkyl-containing metal complexes as contrast media in MR-imaging for visualization of plaque, tumors and necroses
US7160535B2 (en) * 2001-10-31 2007-01-09 Bracco International Bv Conjugates of antioxidants with metal chelating ligands for use in diagnostic and therapeutic applications
US6549798B2 (en) * 2001-02-07 2003-04-15 Epix Medical, Inc. Magnetic resonance angiography data
US6705476B2 (en) * 2001-08-22 2004-03-16 Central Metal Products, Inc. Shipping rack with torsionally loaded shelf
US20050171424A1 (en) * 2004-01-13 2005-08-04 The Gov. Of The Usa As Rep. By The Secretary Of The Dept. Of Health And Human Services Methods for imaging the lymphatic system using dendrimer-based contrast agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118103A1 (en) 1997-10-02 2005-06-02 Epix Medical, Inc., A Delaware Corporation Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
US20060093554A1 (en) 1999-09-29 2006-05-04 Johannes Platzek Galenical formulations
US20060099148A1 (en) 2004-01-15 2006-05-11 Mount Sinai School Of Medicine Methods and compositions for imaging

Also Published As

Publication number Publication date
EP2053968A4 (en) 2015-10-21
EP2053968A2 (en) 2009-05-06
JP5563299B2 (ja) 2014-07-30
CN101528124A (zh) 2009-09-09
KR20090045343A (ko) 2009-05-07
WO2008022263A3 (en) 2008-12-11
CA2660717A1 (en) 2008-02-21
WO2008022263A2 (en) 2008-02-21
US20080044358A1 (en) 2008-02-21
JP2010501009A (ja) 2010-01-14

Similar Documents

Publication Publication Date Title
KR101336505B1 (ko) 림프계의 영상화 방법
CA2303426C (en) Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
Lohrke et al. Preclinical profile of gadoquatrane: a novel tetrameric, macrocyclic high relaxivity gadolinium-based contrast agent
Kiessling et al. Contrast agents and applications to assess tumor angiogenesis in vivo by magnetic resonance imaging
Tan et al. MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model
Wu et al. Synthesis and evaluation of a peptide targeted small molecular Gd-DOTA monoamide conjugate for MR molecular imaging of prostate cancer
US20150050218A1 (en) Dynamic Contrast Enhanced MRI Method And Agents For The Assessment Of The Macromolecular Transport Within Pathologic Tissues
Saeed et al. MR contrast media for myocardial viability, microvascular integrity and perfusion
US20180185520A1 (en) Collagen imaging compostions
US20050171424A1 (en) Methods for imaging the lymphatic system using dendrimer-based contrast agents
Pagoto et al. An efficient MRI agent targeting extracellular markers in prostate adenocarcinoma
Zhou et al. Comparison of Gd [DTPA‐bis (2‐aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: Experimental study with rabbits
HK1131533A (en) Methods for lymph system imaging
Wu et al. MR molecular imaging of prostate cancer with a small molecular CLT1 peptide targeted contrast agent
KR20250158760A (ko) 콜라겐 및 피브린 영상화를 위한 조영제
Dupas et al. Delineation of liver necrosis using double contrast‐enhanced MRI
Yongmin The Comparative Imaging Study on Mn-phthalocyanine and Mangafodipir trisodium in Experimental VX2 Animal Model
Oosterdorp Quantitative contrast-enhanced MRI of the microvasculature
Zhou et al. Results and Discussion: The fibronectin immunostain of tumor slice was shown in Fig. 1. Fluorescence from intravenously injected CREKA peptide (Fig. 1D) and fibronectin staining (Fig. 1C) colocalized (Fig. 1E) in
AU3138702A (en) Contrast-enhanced diagnostic imaging method for monitoring interventional therapies
CZ20001189A3 (cs) Diagnostické činidlo pro monitorování intervenčních terapií
MXPA00002869A (en) Contrast-enhanced diagnostic imaging method for monitoring interventional therapies

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

N231 Notification of change of applicant
PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20161128

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20161128